Matthew Campbell to Insulin, Short-Acting
This is a "connection" page, showing publications Matthew Campbell has written about Insulin, Short-Acting.
Connection Strength
1.513
-
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial. PLoS One. 2014; 9(5):e97143.
Score: 0.454
-
A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes. Diabetes Care. 2014 Jul; 37(7):1845-53.
Score: 0.452
-
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2013 Aug; 36(8):2217-24.
Score: 0.419
-
Application of Machine Learning to Assess Interindividual Variability in Rapid-Acting Insulin Responses After Subcutaneous Injection in People With Type 1 Diabetes. Can J Diabetes. 2022 Apr; 46(3):225-232.e2.
Score: 0.188